Nuclear is back in the AI trade, and small modular reactors are the cleanest way to play it. The two pure-play names retail investors keep asking about are NuScale and Oklo.
Both are pre-revenue. Both are betting that data center demand and policy tailwinds turn paper pipelines into real megawatts this decade.
This is a practical comparison: what each company actually has, what the catalysts look like in 2026, and how to think about position sizing if you want exposure without owning the wrong story.
SMR vs Microreactor: What's the Difference
A small modular reactor is roughly 50 to 300 MW per module, designed to be factory-built and shipped to site. NuScale fits this definition cleanly with its 77 MWe Power Module, which scales to 924 MWe in a 12-module configuration.
A microreactor is typically under 50 MW and targets industrial sites, remote locations, or single data center campuses. Oklo's Aurora was originally a microreactor, then uprated to 75 MW to chase the hyperscaler load.
The distinction matters because regulatory paths and customer profiles diverge. SMRs target utility-scale baseload sold through traditional procurement. Microreactors target behind-the-meter industrial deployment, which is where the AI build-out is moving fastest.
Both designs share factory fabrication and passive safety features. Where they split is go-to-market: licensed to utilities for SMR, owned-and-operated for Oklo's model.
NuScale's NRC-Certified Design and Project Status
NuScale is the only U.S. SMR developer with an NRC-approved design. The Standard Design Approval for its 77 MWe module was issued in May 2025 and remains the company's primary moat.
According to NuScale's Q1 2026 results: the company ended the quarter with $1.0 billion in liquidity, advanced the six-module RoPower project in Romania toward a mid-2026 go/no-go decision, and continued planning with ENTRA1 and TVA on a potential 6 GW U.S. program.
The catch is timing. First commercial revenue from a NuScale reactor probably waits until the early 2030s, which is why even bullish coverage of NuScale stock tends to anchor on the optionality, not near-term earnings.
Oklo's Vertically Integrated Aurora Model
Oklo's pitch is different. Rather than selling reactors, Oklo plans to own, operate, and sell power directly to industrial offtakers under long-dated PPAs.
That vertical model lets Oklo book customer demand without waiting for utility procurement cycles. The 14 GW pipeline is anchored by a 12 GW Switch master agreement, a 500 MW Equinix letter of intent backed by a $25 million prepayment, and a January 2026 partnership with Meta for a 1.2 GW Ohio campus.
Per Yahoo Finance: the NRC approved Aurora's Principal Design Criteria in May 2026, de-risking the path to a combined license application. Commercial deployment at Idaho National Laboratory remains targeted for late 2027.
Side-by-Side: Pipeline, Burn Rate, and Catalysts
NuScale has the regulatory lead and the balance sheet. Oklo has the customer book and the demand narrative. The two profiles do different jobs in a portfolio.
Cash burn favors NuScale's runway. Its $1.0 billion war chest funds the RoPower decision and TVA engineering without near-term dilution risk. Oklo's reported roughly $38 million annual operating burn against roughly $275 million in cash gives several years of runway before any commercial revenue, though future capex for owned reactor builds will materially raise that number.
The 2026 catalysts split cleanly. For SMR, watch the mid-2026 Romania go-decision, TVA program milestones, and any Department of Energy loan-guarantee progress. For OKLO, watch the combined license application submission, the July 2026 Groves Isotopes Test Reactor criticality target, and conversion of Switch and Equinix letters into binding contracts.
Stock-level volatility reflects these differences. OKLO trades like a high-beta thematic, with month-to-month swings of 50% or more not unusual. SMR is calmer but still moves on policy headlines and project updates.
Portfolio Allocation: Hold One, Both, or Pair Trade
If you want one name, the call depends on what you are buying. NuScale is the regulated, balance-sheet-supported way to own SMR optionality. Oklo is the higher-beta hyperscaler demand play.
If you want both, a barbell makes sense: a smaller core in NuScale for regulatory certainty, a smaller satellite in Oklo for AI-power torque. A common framing investors use is 60/40 NuScale to Oklo if you prioritize survivability, or the inverse if you prioritize upside.
For deeper context on Oklo's risk profile, see our prior Oklo stock analysis, which walks through the Sam Altman backing, dilution history, and why it remains a speculative position rather than a core holding.
Conclusion
Neither company is selling power yet, so position sizing matters more than thesis purity. The honest answer to which SMR stock wins is that they win on different dimensions, and a paired position captures both.
Treat SMR and OKLO as venture-style exposure inside a diversified portfolio. The reactor decade is real, but the path from press release to revenue is long and lumpy.
Want to start investing in nuclear names like NuScale or Oklo? Open a Gotrade account from $1 and build your position with fractional shares.
FAQ
Is NuScale the only NRC-certified SMR design?
Yes. NuScale's 77 MWe Power Module received Standard Design Approval in May 2025 and remains the only NRC-certified SMR design in the U.S. queue.
What is Oklo's biggest customer commitment?
Oklo's 12 GW non-binding Master Power Agreement with Switch through 2044 is the anchor of its 14 GW customer pipeline.
When could either company generate real revenue?
Oklo targets late 2027 commercial deployment at Idaho National Laboratory, while NuScale's first reactor revenue is more likely in the early 2030s.
Should I own both SMR and OKLO?
A barbell position is reasonable if you want regulatory certainty plus hyperscaler demand exposure, sized as venture-style allocations within a diversified portfolio.
